<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02583074</url>
  </required_header>
  <id_info>
    <org_study_id>ZYLX201305</org_study_id>
    <nct_id>NCT02583074</nct_id>
  </id_info>
  <brief_title>Clinical Trial of STN-DBS for Primary Cranial-Cervical Dystonia</brief_title>
  <acronym>STN-CCD</acronym>
  <official_title>Subthalamic Deep Brain Stimulation in Patients With Medication-Refractory Primary Cranial-Cervical Dystonia: A Randomised, Sham-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Dalian Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary cranial-cervical dystonia is managed mainly by repeated botulinum toxin
      injections.This study is to establish whether subthalamic nucleus neurostimulation could
      improve symptoms in patients not adequately responding to chemodenervation or oral drug
      treatment. Investigators compared this surgical treatment with sham stimulation in a
      randomized, controlled clinical trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this randomised, sham-controlled trial, investigators will recruit forty patients with
      primary cranial-cervical dystonia to receive an implanted device for STN-DBS, and
      participants will be randomly assigned to receive either neurostimulation or sham stimulation
      for 3 months.The primary end point was the change from baseline to 3 months in the severity
      of symptoms, according to the Burke-Fahn-Marsden Dystonia Rating Scale. Two masked dystonia
      experts who unaware of treatment status will assess the severity of dystonia by reviewing
      standardised videos.Subsequently, all patients will receive open-label neurostimulation;
      blinded assessment will be repeated after 6 months of active treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 15, 2015</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of motor and disability scores</measure>
    <time_frame>Baseline,3 months after surgery, 6 months after active stimulation</time_frame>
    <description>Burke-Fahn-Marsden Dystonia Rating Scale (movement and disability scores, BFMDRSM/D)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Baseline,3 months after surgery,6 months after active stimulation</time_frame>
    <description>SF-36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>Baseline,3 months after surgery,6 months after active stimulation</time_frame>
    <description>Beck Depression Inventory</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Adverse event</measure>
    <time_frame>3 months after surgery,6 months after active stimulation</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Dystonia</condition>
  <arm_group>
    <arm_group_label>Stimulation Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in 'Neurostimulation Group' will receive subthalamic nucleus deep brain stimulation for 3 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham-stimulation Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients in 'Sham-stimulation Group' will receive sham stimulation of subthalamic nucleus for 3 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stimulation</intervention_name>
    <description>After surgery, patients in 'Neurostimulation Group' will receive subthalamic nucleus stimulation for 3 months.</description>
    <arm_group_label>Stimulation Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham-stimulation</intervention_name>
    <description>After surgery, patients in 'sham-stimulation Group' will receive subthalamic nucleus sham-stimulation for 3 months.</description>
    <arm_group_label>Sham-stimulation Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Clinical diagnosis of primary cranial-cervical dystonia: blepharospasm combined with
             dystonia of the lower facial muscles. Cervical muscles can be involved but did not
             dominate the clinical picture.

          2. Medical intractable：including various drugs and local botulinum toxin injections.

          3. patients deteriorated in activities of daily living and showed social withdrawal
             during the course of their disease as they suffered from apparent hyperkinesia of
             facial muscles and functional blindness secondary to severe blepharospasm.

        Exclusion Criteria:

          1. All other topographical areas remained unaffected.

          2. Secondary causes will be excluded by standard cranial magnetic resonance imaging (MRI)
             scans.

          3. Cognitive impairment, dementia,severe psychiatric diseases as well as higher surgical
             risks due to comorbidities will also be exclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhang Jian-guo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tiantan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhang Kai, MD</last_name>
    <phone>861067096767</phone>
    <email>zhangkai62035@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital Affiliated to Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhang Jianguo, MD</last_name>
      <phone>8610-67096767</phone>
      <phone_ext>6767</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Zhang Kai, MD</last_name>
      <phone>8610-67096767</phone>
      <phone_ext>6767</phone_ext>
      <email>zhangkai62035@sina.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital Affiliated to Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhang Jianguo, MD</last_name>
      <phone>8610-67096767</phone>
      <phone_ext>6767</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Zhang Kai, MD</last_name>
      <phone>8610-67096767</phone>
      <phone_ext>6767</phone_ext>
      <email>zhangkai62035@sina.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Skogseid IM. Pallidal deep brain stimulation is effective, and improves quality of life in primary segmental and generalized dystonia. Acta Neurol Scand Suppl. 2008;188:51-5. doi: 10.1111/j.1600-0404.2008.01032.x. Review.</citation>
    <PMID>18439222</PMID>
  </results_reference>
  <results_reference>
    <citation>Limotai N, Go C, Oyama G, Hwynn N, Zesiewicz T, Foote K, Bhidayasiri R, Malaty I, Zeilman P, Rodriguez R, Okun MS. Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical dystonia symptoms. J Neurol. 2011 Nov;258(11):2069-74. doi: 10.1007/s00415-011-6075-0. Epub 2011 May 7.</citation>
    <PMID>21553081</PMID>
  </results_reference>
  <results_reference>
    <citation>Reese R, Gruber D, Schoenecker T, Bäzner H, Blahak C, Capelle HH, Falk D, Herzog J, Pinsker MO, Schneider GH, Schrader C, Deuschl G, Mehdorn HM, Kupsch A, Volkmann J, Krauss JK. Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation. Mov Disord. 2011 Mar;26(4):691-8. doi: 10.1002/mds.23549. Epub 2011 Feb 10.</citation>
    <PMID>21312284</PMID>
  </results_reference>
  <results_reference>
    <citation>Ostrem JL, Markun LC, Glass GA, Racine CA, Volz MM, Heath SL, de Hemptinne C, Starr PA. Effect of frequency on subthalamic nucleus deep brain stimulation in primary dystonia. Parkinsonism Relat Disord. 2014 Apr;20(4):432-8. doi: 10.1016/j.parkreldis.2013.12.012. Epub 2014 Jan 5.</citation>
    <PMID>24440061</PMID>
  </results_reference>
  <results_reference>
    <citation>Cao C, Pan Y, Li D, Zhan S, Zhang J, Sun B. Subthalamus deep brain stimulation for primary dystonia patients: a long-term follow-up study. Mov Disord. 2013 Nov;28(13):1877-82. doi: 10.1002/mds.25586. Epub 2013 Jul 16.</citation>
    <PMID>23861342</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2015</study_first_submitted>
  <study_first_submitted_qc>October 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2015</study_first_posted>
  <last_update_submitted>March 17, 2018</last_update_submitted>
  <last_update_submitted_qc>March 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Kai Zhang</investigator_full_name>
    <investigator_title>PhD，MD</investigator_title>
  </responsible_party>
  <keyword>deep brain stimulation</keyword>
  <keyword>Subthalamic Nucleus</keyword>
  <keyword>dystonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Dystonic Disorders</mesh_term>
    <mesh_term>Torticollis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

